Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology

Free Medical Books

  Autoimmune Disorders

  Free Subscription


Articles published in Neurology

Retrieve available abstracts of 206 articles:
HTML format
Text format



Single Articles


    January 2012
  1. FOX RJ , Rudick RA
    Risk stratification and patient counseling for natalizumab in multiple sclerosis.
    Neurology. 2012.
    PubMed     Text format     Related articles    Abstract available



  2. QUINTANA FJ , Farez MF, Izquierdo G, Lucas M, et al
    Antigen microarrays identify CNS-produced autoantibodies in RRMS.
    Neurology. 2012.
    PubMed     Text format     Related articles    Abstract available



    December 2011
  3. LUNEMANN JD
    Epstein-Barr virus in multiple sclerosis: A continuing conundrum.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available



    November 2011
  4. WIEBENGA OT , Hulst HE, Kooi EJ, Killestein J, et al
    Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis.
    Neurology. 2011;77:1998-2000.
    PubMed     Text format     Related articles   



  5. HEILMAN KM , Williamson JB
    Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis.
    Neurology. 2011;77:1998-9.
    PubMed     Text format     Related articles   



  6. RAMMOHAN KW , Ortega MR, Delgado SR, Tornes L, et al
    Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis.
    Neurology. 2011;77:1930-1.
    PubMed     Text format     Related articles   



  7. ALBAYRAM S , Kantarci F
    Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS.
    Neurology. 2011;77:e126.
    PubMed     Text format     Related articles   



  8. BARACCHINI C , Gallo P
    Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS.
    Neurology. 2011;77:e124-5.
    PubMed     Text format     Related articles   



  9. MOROVIC S , Menegatti E
    Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS.
    Neurology. 2011;77:e124.
    PubMed     Text format     Related articles   



  10. RIDDELL CA , Zhao Y, Li DK, Petkau AJ, et al
    Evaluation of safety monitoring guidelines based on MRI lesion activity in multiple sclerosis.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available



  11. BIELEKOVA B , Richert N, Herman ML, Ohayon J, et al
    Intrathecal effects of daclizumab treatment of multiple sclerosis.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available



  12. MARTINELLI V , Cocco E, Capra R, Salemi G, et al
    Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available



  13. GIORGIO A , Stromillo ML, Rossi F, Battaglini M, et al
    Cortical lesions in radiologically isolated syndrome.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available



  14. FUEHRER NE , Hammack JE, Morris JM, Kaufmann TJ, et al
    Teaching NeuroImages: Granulomatous angiitis of the CNS associated with Hodgkin lymphoma.
    Neurology. 2011;77:e110-1.
    PubMed     Text format     Related articles   



  15. ZIVADINOV R , Marr K
    Comment on "Chronic cerebrospinal venous insufficiency: have we found the cause and cure of MS?".
    Neurology. 2011;77:1710.
    PubMed     Text format     Related articles   



  16. ROVIRA A , Montalban X
    MR brain iron mapping in MS: a potential neurodegenerative marker or just another technique?
    Neurology. 2011;77:1660-1.
    PubMed     Text format     Related articles   



  17. WOLINSKY JS , Beck CA
    The long march to surrogates of meaningful clinical outcomes in MS trials: are we there yet?
    Neurology. 2011;77:1658-9.
    PubMed     Text format     Related articles   



    October 2011
  18. DOEPP F , Wurfel JT, Pfueller CF, Valdueza JM, et al
    Venous drainage in multiple sclerosis: A combined MRI and ultrasound study.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available



  19. SOLOMON AJ
    Multiple sclerosis and vitamin D.
    Neurology. 2011;77:e99-e100.
    PubMed     Text format     Related articles   



  20. STEIN MS , Liu Y, Gray OM, Baker JE, et al
    A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.
    Neurology. 2011;77:1611-8.
    PubMed     Text format     Related articles    Abstract available



  21. IORIO R , Lucchinetti CF, Lennon VA, Costanzi C, et al
    Syndrome of inappropriate antidiuresis may herald or accompany neuromyelitis optica.
    Neurology. 2011;77:1644-6.
    PubMed     Text format     Related articles   



  22. EVOLI A , Lindstrom J
    Myasthenia gravis with antibodies to MuSK: Another step toward solving mystery?
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available



  23. KAWAKAMI Y , Ito M, Hirayama M, Sahashi K, et al
    Anti-MuSK autoantibodies block binding of collagen Q to MuSK.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available



  24. BENARROCH EE
    Nitric oxide: A pleiotropic signal in the nervous system.
    Neurology. 2011;77:1568-76.
    PubMed     Text format     Related articles   



  25. FREEDMAN MS , Bar-Or A, Oger J, Traboulsee A, et al
    A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS.
    Neurology. 2011;77:1551-60.
    PubMed     Text format     Related articles    Abstract available



  26. PATY DW , Li DK
    Interferon beta-1b is effective in relapsing-remitting multiple-sclerosis: II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial.
    Neurology. 2011;77:1431.
    PubMed     Text format     Related articles   



  27. KHALIL M , Langkammer C, Ropele S, Petrovic K, et al
    Determinants of brain iron in multiple sclerosis: A quantitative 3T MRI study.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available



  28. ABBAS M , Lalive PH, Chofflon M, Simon HU, et al
    Hypereosinophilia in patients with multiple sclerosis treated with natalizumab.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available



  29. P SORMANI M , Li DK, Bruzzi P, Stubinski B, et al
    Combined MRI lesions and relapses as a surrogate for disability in multiple sclerosis.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available



    September 2011
  30. BARRETO AD
    Time to reevaluate the role of venous hemodynamics in MS pathophysiology?: Controversy mounts.
    Neurology. 2011;77:1218-9.
    PubMed     Text format     Related articles   



  31. RAO SM , Leo GJ, Haughton VM, St Aubin-Faubert P, et al
    Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis.
    Neurology. 2011;77:1134.
    PubMed     Text format     Related articles   



  32. MATIELLO M , Schaefer-Klein JL, Hebrink DD, Kingsbury DJ, et al
    Genetic analysis of aquaporin-4 in neuromyelitis optica.
    Neurology. 2011;77:1149-55.
    PubMed     Text format     Related articles    Abstract available



  33. SCALFARI A , Neuhaus A, Daumer M, Ebers GC, et al
    Age and disability accumulation in multiple sclerosis.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available



  34. KO MY , Stefoski D, Balabanov R
    Indolent course of progressive multifocal leukoencephalopathy during natalizumab treatment in MS.
    Neurology. 2011;77:1020.
    PubMed     Text format     Related articles   



    August 2011
  35. HARTUNG HP , Freedman MS, Polman CH, Edan G, et al
    Interferon beta-1b-neutralizing antibodies 5 years after clinically isolated syndrome.
    Neurology. 2011;77:835-43.
    PubMed     Text format     Related articles    Abstract available



  36. SIRITHO S , Nakashima I, Takahashi T, Fujihara K, et al
    AQP4 antibody-positive Thai cases: clinical features and diagnostic problems.
    Neurology. 2011;77:827-34.
    PubMed     Text format     Related articles    Abstract available



  37. WEINSHENKER BG , Carroll WM
    Does detection of anti-AQP4 antibodies trump clinical criteria for neuromyelitis optica?
    Neurology. 2011;77:812-3.
    PubMed     Text format     Related articles   



  38. LINDSTROM JM , Seybold ME, Lennon VA, Whittingham S, et al
    Antibody to acetylcholine receptor in myasthenia gravis: Prevalence, clinical correlates, and diagnostic value.
    Neurology. 2011;77:783.
    PubMed     Text format     Related articles   



  39. BARACCHINI C , Perini P, Causin F, Calabrese M, et al
    Progressive multiple sclerosis is not associated with chronic cerebrospinal venous insufficiency.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available



  40. TSIVGOULIS G , Mantatzis M, Bogiatzi C, Vadikolias K, et al
    Extracranial venous hemodynamics in multiple sclerosis: A case-control study.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available



  41. CHIBA A , Kusunoki S, Obata H, Machinami R, et al
    Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barre syndrome: Clinical and immunohistochemical studies.
    Neurology. 2011;77:676.
    PubMed     Text format     Related articles   



  42. COSTANZI C , Matiello M, Lucchinetti CF, Weinshenker BG, et al
    Azathioprine: tolerability, efficacy, and predictors of benefit in neuromyelitis optica.
    Neurology. 2011;77:659-66.
    PubMed     Text format     Related articles    Abstract available



  43. CHAO MJ , Lincoln MR, Dyment DA, Ramagopalan SV, et al
    HLA B*44: Protective effects in MS susceptibility and MRI outcome measures.
    Neurology. 2011;77:602-3.
    PubMed     Text format     Related articles   



  44. OH KP , Lee YJ, Bae SC, Baek W, et al
    Intractable progressive pneumocephalus due to tuberculous meningoencephalitis.
    Neurology. 2011;77:600-1.
    PubMed     Text format     Related articles   



  45. PROBSTEL AK , Dornmair K, Bittner R, Sperl P, et al
    Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis.
    Neurology. 2011;77:580-8.
    PubMed     Text format     Related articles    Abstract available



  46. KANAMORI Y , Nakashima I, Takai Y, Nishiyama S, et al
    Pain in neuromyelitis optica and its effect on quality of life: A cross-sectional study.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available



  47. CHHIBBER S , Greenberg SA
    Teaching Video NeuroImages: Widespread clinical myokymia in chronic inflammatory demyelinating polyradiculoneuropathy.
    Neurology. 2011;77:e33.
    PubMed     Text format     Related articles   



    July 2011
  48. COSSBURN M , Pace AA, Jones J, Ali R, et al
    Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available



  49. WASCHBISCH A , Sandbrink R, Hartung HP, Kappos L, et al
    Evaluation of soluble HLA-G as a biomarker for multiple sclerosis.
    Neurology. 2011.
    PubMed     Text format     Related articles   



  50. MINEN MT , Karceski S
    Multiple sclerosis and disease-modifying therapies.
    Neurology. 2011;77:e26.
    PubMed     Text format     Related articles   



  51. LUCAS RM , Ponsonby AL, Dear K, Valery P, et al
    Current and past Epstein-Barr virus infection in risk of initial CNS demyelination.
    Neurology. 2011;77:371-9.
    PubMed     Text format     Related articles    Abstract available



  52. SMYTH KA
    Cost-effectiveness analyses of treatments for multiple sclerosis: Are they clinically relevant?
    Neurology. 2011.
    PubMed     Text format     Related articles   



  53. STOSIC M , De Jesus P, McCarthy J, Hutton G, et al
    Immune thrombocytopenic purpura in a patient with multiple sclerosis treated with natalizumab.
    Neurology. 2011.
    PubMed     Text format     Related articles   



  54. NOYES K , Bajorska A, Chappel A, Schwid SR, et al
    Cost-effectiveness of disease-modifying therapy for multiple sclerosis: A population-based study.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available



  55. MOEN SM , Celius EG, Sandvik L, Nordsletten L, et al
    Low bone mass in newly diagnosed multiple sclerosis and clinically isolated syndrome.
    Neurology. 2011;77:151-7.
    PubMed     Text format     Related articles    Abstract available



  56. BOMPREZZI R , Powers JM, Shimizu J, Tsuji S, et al
    IFNbeta-1b may severely exacerbate Japanese opticspinal MS in neuromyelitis optica spectrum: Japanese optic-spinal MS: is it MS or neuromyelitis optica and does the answer dictate treatment?
    Neurology. 2011;77:195.
    PubMed     Text format     Related articles   



  57. NEWEY CR , Bermel RA
    Fulminant cerebral demyelination in neuromyelitis optica.
    Neurology. 2011;77:193.
    PubMed     Text format     Related articles   



  58. ZIVADINOV R , Marr K, Cutter G, Ramanathan M, et al
    Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS.
    Neurology. 2011;77:138-44.
    PubMed     Text format     Related articles    Abstract available



  59. FOX RJ , Rae-Grant A
    Chronic cerebrospinal venous insufficiency: have we found the cause and cure of MS?
    Neurology. 2011;77:98-100.
    PubMed     Text format     Related articles   



  60. PORTACCIO E , Ghezzi A, Hakiki B, Martinelli V, et al
    Breastfeeding is not related to postpartum relapses in multiple sclerosis.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available



    June 2011
  61. FANG L , Isobe N, Yoshimura S, Yonekawa T, et al
    Interleukin-7 receptor alpha gene polymorphism influences multiple sclerosis risk in Asians.
    Neurology. 2011;76:2125-2127.
    PubMed     Text format     Related articles   



  62. BRENNER SR
    Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiency.
    Neurology. 2011;76:2130.
    PubMed     Text format     Related articles   



  63. HAUPTS MR , Meyer-Schwickerath R, Hacker A, Haug C, et al
    Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiency.
    Neurology. 2011;76:2131.
    PubMed     Text format     Related articles   



  64. SENA A , Pedrosa R, Ferret-Sena V
    Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiency.
    Neurology. 2011;76:2130-1.
    PubMed     Text format     Related articles   



  65. ROCCA MA , Horsfield MA, Sala S, Copetti M, et al
    A multicenter assessment of cervical cord atrophy among MS clinical phenotypes.
    Neurology. 2011;76:2096-102.
    PubMed     Text format     Related articles    Abstract available



  66. GHOLIPOUR T , Healy B, Baruch NF, Weiner HL, et al
    Demographic and clinical characteristics of malignant multiple sclerosis.
    Neurology. 2011;76:1996-2001.
    PubMed     Text format     Related articles    Abstract available



  67. WAUBANT E , Mowry EM, Krupp L, Chitnis T, et al
    Common viruses associated with lower pediatric multiple sclerosis risk.
    Neurology. 2011;76:1989-1995.
    PubMed     Text format     Related articles    Abstract available



    May 2011
  68. THOUVENOT E , Schmidt C, Heroum C, Carlander B, et al
    Diabetes insipidus as a first manifestation in multiple sclerosis.
    Neurology. 2011;76:1939-40.
    PubMed     Text format     Related articles   



  69. RIISE T , Mohr DC, Munger KL, Rich-Edwards JW, et al
    Stress and the risk of multiple sclerosis.
    Neurology. 2011;76:1866-71.
    PubMed     Text format     Related articles    Abstract available



  70. VIRMANI T , Agarwal A, Klawiter EC
    Clinical reasoning: A young adult presents with focal weakness and hemorrhagic brain lesions.
    Neurology. 2011;76:e106-9.
    PubMed     Text format     Related articles   



  71. CHARD DT , Geurts JJ
    Predicting the development of multiple sclerosis: Is gray matter a missing piece of the puzzle?
    Neurology. 2011.
    PubMed     Text format     Related articles   



  72. SOMBEKKE MH , Jafari N, Bendfeldt K, Mueller-Lenke N, et al
    No influence of KIF1B on neurodegenerative markers in multiple sclerosis.
    Neurology. 2011;76:1843-5.
    PubMed     Text format     Related articles   



  73. GELFAND JM , Cree BA, McElroy J, Oksenberg J, et al
    Vitamin D in African Americans with multiple sclerosis.
    Neurology. 2011;76:1824-30.
    PubMed     Text format     Related articles    Abstract available



  74. PUTAALA J , Liebkind R, Gordin D, Thorn LM, et al
    Diabetes mellitus and ischemic stroke in the young: Clinical features and long-term prognosis.
    Neurology. 2011;76:1831-7.
    PubMed     Text format     Related articles    Abstract available



  75. PANITCH HS , Hirsch RL, Schindler J, Johnson KP, et al
    Treatment of multiple sclerosis with gamma interferon: Exacerbations associated with activation of the immune system.
    Neurology. 2011;76:1734.
    PubMed     Text format     Related articles   



  76. POPESCU BF , Bunyan RF, Parisi JE, Ransohoff RM, et al
    A case of multiple sclerosis presenting with inflammatory cortical demyelination.
    Neurology. 2011;76:1705-10.
    PubMed     Text format     Related articles    Abstract available



  77. VERMERSCH P , Kappos L, Gold R, Foley JF, et al
    Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy.
    Neurology. 2011;76:1697-704.
    PubMed     Text format     Related articles    Abstract available



  78. CLIFFORD DB
    Time is brain for infections too?
    Neurology. 2011;76:1688-9.
    PubMed     Text format     Related articles   



  79. BARTH D , Nabavi Nouri M, Ng E, Nwe P, et al
    Comparison of IVIg and PLEX in patients with myasthenia gravis.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available



  80. LATERRE EC , Callewaert A, Heremans JF, Sfaello Z, et al
    Electrophoretic morphology of gamma globulins in cerebrospinal fluid of multiple sclerosis and other diseases of the nervous system.
    Neurology. 2011;76:1667.
    PubMed     Text format     Related articles   



  81. TILIKETE C , Jasse L, Pelisson D, Vukusic S, et al
    Acquired pendular nystagmus in multiple sclerosis and oculopalatal tremor.
    Neurology. 2011;76:1650-7.
    PubMed     Text format     Related articles    Abstract available



  82. NAISMITH RT , Bourdette D
    Interruption of natalizumab therapy for multiple sclerosis: What are the risks?
    Neurology. 2011.
    PubMed     Text format     Related articles   



  83. O'CONNOR PW , Goodman A, Kappos L, Lublin FD, et al
    Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis.
    Neurology. 2011.
    PubMed     Text format     Related articles   



  84. ASGARI N , Lillevang ST, Skejoe HP, Falah M, et al
    A population-based study of neuromyelitis optica in Caucasians.
    Neurology. 2011;76:1589-95.
    PubMed     Text format     Related articles    Abstract available



    April 2011
  85. NEUTEBOOM RF , Hintzen RQ, Airas L
    Breast-feeding, postpartum and prepregnancy disease activity in multiple sclerosis.
    Neurology. 2011;76:1532-3.
    PubMed     Text format     Related articles   



  86. PAKZAD Z , Aziz T, Oger J
    Increasing incidence of myasthenia gravis among elderly in British Columbia, Canada.
    Neurology. 2011;76:1526-8.
    PubMed     Text format     Related articles   



  87. KRUPP LB , Christodoulou C, Melville P, Scherl WF, et al
    Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis.
    Neurology. 2011;76:1500-7.
    PubMed     Text format     Related articles   



  88. BRILOT F , Merheb V, Ding A, Murphy T, et al
    Antibody binding to neuronal surface in Sydenham chorea, but not in PANDAS or Tourette syndrome.
    Neurology. 2011;76:1508-13.
    PubMed     Text format     Related articles    Abstract available



  89. GRAUS F , Cordon-Cardo C, Posner JB
    Neuronal antinuclear antibody in sensory neuronopathy from lung cancer.
    Neurology. 2011;76:1414.
    PubMed     Text format     Related articles   



  90. RAMAGOPALAN SV , Handel AE, Giovannoni G, Rutherford Siegel S, et al
    Relationship of UV exposure to prevalence of multiple sclerosis in England.
    Neurology. 2011;76:1410-4.
    PubMed     Text format     Related articles    Abstract available



  91. OTTO C , Oltmann A, Stein A, Frenzel K, et al
    Intrathecal EBV antibodies are part of the polyspecific immune response in multiple sclerosis.
    Neurology. 2011;76:1316-21.
    PubMed     Text format     Related articles    Abstract available



  92. PELLKOFER HL , Krumbholz M, Berthele A, Hemmer B, et al
    Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab.
    Neurology. 2011;76:1310-5.
    PubMed     Text format     Related articles    Abstract available



  93. FILIPPI M , Rocca MA, Camesasca F, Cook S, et al
    Interferon beta-1b and glatiramer acetate effects on permanent black hole evolution.
    Neurology. 2011;76:1222-8.
    PubMed     Text format     Related articles    Abstract available



  94. KOWARIK MC , Pellkofer HL, Cepok S, Korn T, et al
    Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MS.
    Neurology. 2011;76:1214-21.
    PubMed     Text format     Related articles    Abstract available



  95. POPESCU BF , Lennon VA, Parisi JE, Howe CL, et al
    Neuromyelitis optica unique area postrema lesions: nausea, vomiting, and pathogenic implications.
    Neurology. 2011;76:1229-37.
    PubMed     Text format     Related articles    Abstract available



  96. GIOVANNONI G , Nath A
    After the storm: neurofilament levels as a surrogate endpoint for neuroaxonal damage.
    Neurology. 2011;76:1200-1.
    PubMed     Text format     Related articles   



    March 2011
  97. DELOIRE MS , Ruet A, Hamel D, Bonnet M, et al
    MRI predictors of cognitive outcome in early multiple sclerosis.
    Neurology. 2011;76:1161-7.
    PubMed     Text format     Related articles    Abstract available



  98. HONARMAND K , Tierney MC, O'Connor P, Feinstein A, et al
    Effects of cannabis on cognitive function in patients with multiple sclerosis.
    Neurology. 2011;76:1153-60.
    PubMed     Text format     Related articles    Abstract available



  99. MCKEON A , Pittock SJ, Lennon VA
    CSF complements serum for evaluating paraneoplastic antibodies and NMO-IgG.
    Neurology. 2011;76:1108-10.
    PubMed     Text format     Related articles   



  100. FASSAS A , Kimiskidis VK, Sakellari I, Kapinas K, et al
    Long-term results of stem cell transplantation for MS: a single-center experience.
    Neurology. 2011;76:1066-70.
    PubMed     Text format     Related articles    Abstract available



  101. EBERS GC , Daumer M, Scalfari A, Rudick R, et al
    Surrogate endpoints for EDSS worsening in multiple sclerosis: A meta-analytic approach: Measuring disability in relapsing-remitting MS.
    Neurology. 2011;76:1025-6.
    PubMed     Text format     Related articles   



  102. WALGAARD C , Lingsma HF, Ruts L, van Doorn PA, et al
    Early recognition of poor prognosis in Guillain-Barre syndrome.
    Neurology. 2011;76:968-75.
    PubMed     Text format     Related articles    Abstract available



  103. UCCELLI A , Ginocchio F, Mancardi GL, Bassetti M, et al
    Primary varicella zoster infection associated with fingolimod treatment.
    Neurology. 2011;76:1023-4.
    PubMed     Text format     Related articles   



  104. ABSINTA M , Rocca MA, Moiola L, Copetti M, et al
    Cortical lesions in children with multiple sclerosis.
    Neurology. 2011;76:910-3.
    PubMed     Text format     Related articles    Abstract available



  105. SOFRONIEW MV
    Neuromyelitis optica: Circulating autoantibodies provoke astrocyte-mediated neural dysfunction.
    Neurology. 2011.
    PubMed     Text format     Related articles   



  106. BONNET M , Deloire M, Brochet B, Sumowski JF, et al
    Intellectual enrichment lessens the effect of brain atrophy on learning and memory in multiple sclerosis.
    Neurology. 2011;76:847-8.
    PubMed     Text format     Related articles   



  107. DIFRANCESCO JC , Brioschi M, Brighina L, Ruffmann C, et al
    Anti-A{beta} autoantibodies in the CSF of a patient with CAA-related inflammation: A case report.
    Neurology. 2011;76:842-4.
    PubMed     Text format     Related articles   



  108. ROODBOL J , de Wit MC, Walgaard C, de Hoog M, et al
    Recognizing Guillain-Barre syndrome in preschool children.
    Neurology. 2011;76:807-10.
    PubMed     Text format     Related articles    Abstract available



  109. ISOHANNI P , Hakonen AH, Euro L, Paetau I, et al
    POLG1 manifestations in childhood.
    Neurology. 2011;76:811-5.
    PubMed     Text format     Related articles    Abstract available



  110. DISANTO G , Magalhaes S, Handel AE, Morrison KM, et al
    HLA-DRB1 confers increased risk of pediatric-onset MS in children with acquired demyelination.
    Neurology. 2011;76:781-6.
    PubMed     Text format     Related articles    Abstract available



    February 2011
  111. KUHLE J , Leppert D, Petzold A, Regeniter A, et al
    Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available



  112. HASAN SK , Buttari F, Ottone T, Voso MT, et al
    Risk of acute promyelocytic leukemia in multiple sclerosis: Coding variants of DNA repair genes.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available



  113. KUNTZER T , Carota A, Novy J, Cavassini M, et al
    Rituximab is successful in an HIV-positive patient with MuSK myasthenia gravis.
    Neurology. 2011;76:757-8.
    PubMed     Text format     Related articles   



  114. SAIFUDHEEN K , Jose J, Gafoor VA, Musthafa M, et al
    Guillain-Barre syndrome and SIADH.
    Neurology. 2011;76:701-4.
    PubMed     Text format     Related articles    Abstract available



  115. HOHLFELD R , Barkhof F, Polman C
    Future clinical challenges in multiple sclerosis: Relevance to sphingosine 1-phosphate receptor modulator therapy.
    Neurology. 2011;76.
    PubMed     Text format     Related articles    Abstract available



  116. MEHLING M , Johnson TA, Antel J, Kappos L, et al
    Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis.
    Neurology. 2011;76.
    PubMed     Text format     Related articles    Abstract available



  117. HLA T , Brinkmann V
    Sphingosine 1-phosphate (S1P): Physiology and the effects of S1P receptor modulation.
    Neurology. 2011;76.
    PubMed     Text format     Related articles    Abstract available



  118. PINSCHEWER DD , Brinkmann V, Merkler D
    Impact of sphingosine 1-phosphate modulation on immune outcomes.
    Neurology. 2011;76.
    PubMed     Text format     Related articles    Abstract available



  119. SORENSEN PS , Koch-Henriksen N, Jensen PE
    Neutralizing antibodies against interferon-beta do not predispose antibodies against natalizumab.
    Neurology. 2011;76:759-60.
    PubMed     Text format     Related articles   



  120. MELKAS S , Putaala J, Oksala NK, Pohjasvaara T, et al
    Small-vessel disease relates to poor poststroke survival in a 12-year follow-up.
    Neurology. 2011;76:734-9.
    PubMed     Text format     Related articles    Abstract available



  121. LOITFELDER M , Fazekas F, Petrovic K, Fuchs S, et al
    Reorganization in cognitive networks with progression of multiple sclerosis: Insights from fMRI.
    Neurology. 2011;76:526-33.
    PubMed     Text format     Related articles    Abstract available



  122. VENNEGOOR A , Wattjes MP, van Munster ET, Kriekaart RL, et al
    Indolent course of progressive multifocal leukoencephalopathy during natalizumab treatment in MS.
    Neurology. 2011;76:574-6.
    PubMed     Text format     Related articles   



  123. LUCAS RM , Ponsonby AL, Dear K, Valery PC, et al
    Sun exposure and vitamin D are independent risk factors for CNS demyelination.
    Neurology. 2011;76:540-8.
    PubMed     Text format     Related articles    Abstract available



  124. TALLANTYRE EC , Dixon JE, Donaldson I, Owens T, et al
    Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions.
    Neurology. 2011;76:534-9.
    PubMed     Text format     Related articles    Abstract available



  125. ORTON SM , Wald L, Confavreux C, Vukusic S, et al
    Association of UV radiation with multiple sclerosis prevalence and sex ratio in France.
    Neurology. 2011;76:425-31.
    PubMed     Text format     Related articles    Abstract available



  126. DHAMIJA R , Moseley BD, Wirrell EC
    Clinical Reasoning: A 10-month-old boy with myoclonic status epilepticus.
    Neurology. 2011;76:e22-5.
    PubMed     Text format     Related articles   



    January 2011
  127. BOURDETTE D , Yadav V
    The radiologically isolated syndrome revisited: When is it presymptomatic multiple sclerosis?
    Neurology. 2011.
    PubMed     Text format     Related articles   



  128. VAN NES SI , Vanhoutte EK, van Doorn PA, Hermans M, et al
    Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies.
    Neurology. 2011;76:337-45.
    PubMed     Text format     Related articles    Abstract available



  129. SELCEN D , Juel VC, Hobson-Webb LD, Smith EC, et al
    Myasthenic syndrome caused by plectinopathy.
    Neurology. 2011;76:327-36.
    PubMed     Text format     Related articles    Abstract available



  130. CORTESE I , Chaudhry V, So YT, Cantor F, et al
    Evidence-based guideline update: Plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Neurology. 2011;76:294-300.
    PubMed     Text format     Related articles    Abstract available



  131. BENARROCH EE
    Na+, K+-ATPase: functions in the nervous system and involvement in neurologic disease.
    Neurology. 2011;76:287-93.
    PubMed     Text format     Related articles   



  132. LEHKY TJ , Iwamoto FM, Kreisl TN, Floeter MK, et al
    Neuromuscular junction toxicity with tandutinib induces a myasthenic-like syndrome.
    Neurology. 2011;76:236-41.
    PubMed     Text format     Related articles    Abstract available



  133. CHAO MJ , Ramagopalan SV, Herrera BM, Orton SM, et al
    MHC transmission: insights into gender bias in MS susceptibility.
    Neurology. 2011;76:242-6.
    PubMed     Text format     Related articles    Abstract available



  134. KANTARCI OH
    Sex-stratified inheritance of MS: new horizons from studies in MHC region.
    Neurology. 2011;76:210-2.
    PubMed     Text format     Related articles   



  135. HARRISON DM , Caffo BS, Shiee N, Farrell JA, et al
    Longitudinal changes in diffusion tensor-based quantitative MRI in multiple sclerosis.
    Neurology. 2011;76:179-86.
    PubMed     Text format     Related articles    Abstract available



  136. RUBIO-AGUSTI I , Perez-Miralles F, Sevilla T, Muelas N, et al
    Peripheral nerve hyperexcitability: a clinical and immunologic study of 38 patients.
    Neurology. 2011;76:172-8.
    PubMed     Text format     Related articles    Abstract available



  137. GEURTS JJ , Roosendaal SD, Calabrese M, Ciccarelli O, et al
    Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI.
    Neurology. 2011.
    PubMed     Text format     Related articles    Abstract available



  138. CHEN JT , Pirko I
    MS cortical lesion or not?: Double inversion recovery MRI reveals some answers and uncertainties.
    Neurology. 2011.
    PubMed     Text format     Related articles   



  139. BATES D
    Long-term outcomes in patients with multiple sclerosis. Introduction.
    Neurology. 2011;76.
    PubMed     Text format     Related articles   



  140. HURWITZ BJ
    Analysis of current multiple sclerosis registries.
    Neurology. 2011;76.
    PubMed     Text format     Related articles    Abstract available



  141. HURWITZ BJ
    Registry studies of long-term multiple sclerosis outcomes: description of key registries.
    Neurology. 2011;76.
    PubMed     Text format     Related articles    Abstract available



  142. FREEDMAN MS
    Long-term follow-up of clinical trials of multiple sclerosis therapies.
    Neurology. 2011;76.
    PubMed     Text format     Related articles    Abstract available



  143. BATES D
    Treatment effects of immunomodulatory therapies at different stages of multiple sclerosis in short-term trials.
    Neurology. 2011;76.
    PubMed     Text format     Related articles    Abstract available



  144. BATES D
    Summary: Registry data.
    Neurology. 2011;76.
    PubMed     Text format     Related articles   



  145. FREEDMAN MS
    Improving long-term follow-up studies of immunomodulatory therapies.
    Neurology. 2011;76.
    PubMed     Text format     Related articles    Abstract available



  146. LONNQVIST T , Isohanni P, Valanne L, Olli-Lahdesmaki T, et al
    Dominant encephalopathy mimicking mitochondrial disease.
    Neurology. 2011;76:101-3.
    PubMed     Text format     Related articles   



    December 2010
  147. JERET JS , Suzuki N, Takahashi T, Fujihara K, et al
    Neuromyelitis optica preceded by hyperCKemia episode.
    Neurology. 2010;75:2253 author reply 2253-4.
    PubMed     Text format     Related articles   



  148. DENHOLM JT , Neal A, Yan B, Petty S, et al
    Acute encephalomyelitis syndromes associated with H1N1 09 influenza vaccination.
    Neurology. 2010;75:2246-8.
    PubMed     Text format     Related articles   



  149. FILIPPI M , Rocca MA, Benedict RH, Deluca J, et al
    The contribution of MRI in assessing cognitive impairment in multiple sclerosis.
    Neurology. 2010;75:2121-8.
    PubMed     Text format     Related articles    Abstract available



  150. ROSS KA , Schwebel DC, Rinker J 2nd, Ness J, et al
    Neurocognitive sequelae in African American and Caucasian children with multiple sclerosis.
    Neurology. 2010;75:2097-102.
    PubMed     Text format     Related articles    Abstract available



  151. POPESCU BF , Parisi JE, Cabrera-Gomez JA, Newell K, et al
    Absence of cortical demyelination in neuromyelitis optica.
    Neurology. 2010;75:2103-9.
    PubMed     Text format     Related articles    Abstract available



  152. MARRIE RA
    Cognitive test results in pediatric MS: what do racial disparities tell us?
    Neurology. 2010;75:2054-5.
    PubMed     Text format     Related articles   



    November 2010
  153. FILIPPI M , Rocca MA, Calabrese M, Sormani MP, et al
    Intracortical lesions: Relevance for new MRI diagnostic criteria for multiple sclerosis.
    Neurology. 2010;75:1988-94.
    PubMed     Text format     Related articles    Abstract available



  154. TINTORE M , Rovira A, Arrambide G, Mitjana R, et al
    Brainstem lesions in clinically isolated syndromes.
    Neurology. 2010;75:1933-8.
    PubMed     Text format     Related articles    Abstract available



  155. NORCLIFFE-KAUFMANN L , Axelrod F, Kaufmann H
    Afferent baroreflex failure in familial dysautonomia.
    Neurology. 2010;75:1904-11.
    PubMed     Text format     Related articles    Abstract available



  156. AMATO MP , Portaccio E, Ghezzi A, Hakiki B, et al
    Pregnancy and fetal outcomes after interferon-{beta} exposure in multiple sclerosis.
    Neurology. 2010;75:1794-1802.
    PubMed     Text format     Related articles    Abstract available



  157. MILLICHAP JJ , Goldstein JL
    Teaching NeuroImages: long-term outcome of untreated Rasmussen syndrome.
    Neurology. 2010;75:e85.
    PubMed     Text format     Related articles   



  158. TANAKA Y , Kimura K, Kawachi I, Inuzuka T, et al
    No relapse of neuromyelitis optica during drug-induced B-lymphopenia with hypogammaglobulinemia.
    Neurology. 2010;75:1745-7.
    PubMed     Text format     Related articles   



  159. HUPPKE P , Bluthner M, Bauer O, Stark W, et al
    Neuromyelitis optica and NMO-IgG in European pediatric patients.
    Neurology. 2010;75:1740-4.
    PubMed     Text format     Related articles    Abstract available



  160. MIRAVALLE A , Corboy JR
    Therapeutic options in multiple sclerosis: Five new things.
    Neurology. 2010;75.
    PubMed     Text format     Related articles    Abstract available



  161. SCHMALSTIEG WF , Weinshenker BG
    Approach to acute or subacute myelopathy.
    Neurology. 2010;75.
    PubMed     Text format     Related articles   



  162. BENYOUNES N , Gout O
    Fatigue and dizziness during steroid perfusion.
    Neurology. 2010;75:1656-7.
    PubMed     Text format     Related articles   



  163. RENARD D , Taieb G, Castelnovo G, Labauge P, et al
    Teaching Video NeuroImages: Painful legs, moving toes associated with partial transverse myelitis.
    Neurology. 2010;75:e74.
    PubMed     Text format     Related articles   



  164. WORTHINGTON V , Killestein J, Eikelenboom MJ, Teunissen CE, et al
    Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiency.
    Neurology. 2010;75:1617-22.
    PubMed     Text format     Related articles    Abstract available



    October 2010
  165. RISON RA , Berkovich R
    Teaching NeuroImages: hiccoughs and vomiting in neuromyelitis optica.
    Neurology. 2010;75:e70.
    PubMed     Text format     Related articles   



  166. KIM NH , Kim HJ, Cheong HK, Kim BJ, et al
    Prevalence of multiple sclerosis in Korea.
    Neurology. 2010;75:1432-1438.
    PubMed     Text format     Related articles    Abstract available



  167. SUMOWSKI JF , Wylie GR, Gonnella A, Chiaravalloti N, et al
    Premorbid cognitive leisure independently contributes to cognitive reserve in multiple sclerosis.
    Neurology. 2010;75:1428-31.
    PubMed     Text format     Related articles    Abstract available



  168. TSIVGOULIS G , Heliopoulos I, Vadikolias K, Patousi A, et al
    Teaching NeuroImages: Ultrasound findings in giant-cell arteritis.
    Neurology. 2010;75:e67-8.
    PubMed     Text format     Related articles   



  169. SHIMIZU J , Hatanaka Y, Hasegawa M, Iwata A, et al
    IFNbeta-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum.
    Neurology. 2010;75:1423-7.
    PubMed     Text format     Related articles    Abstract available



  170. WEINSHENKER BG , Wingerchuk DM
    Japanese optic-spinal MS: is it MS or neuromyelitis optica and does the answer dictate treatment?
    Neurology. 2010;75:1404-5.
    PubMed     Text format     Related articles   



  171. ZHANG Y , Metz LM
    Dominant perivenular enhancement of tumefactive demyelinating lesions in multiple sclerosis.
    Neurology. 2010;75:1396.
    PubMed     Text format     Related articles   



  172. AMEND KL , Turnbull B, Foskett N, Napalkov P, et al
    Incidence of progressive multifocal leukoencephalopathy in patients without HIV.
    Neurology. 2010;75:1326-32.
    PubMed     Text format     Related articles    Abstract available



  173. BONNET MC , Allard M, Dilharreguy B, Deloire M, et al
    Cognitive compensation failure in multiple sclerosis.
    Neurology. 2010;75:1241-8.
    PubMed     Text format     Related articles    Abstract available



  174. REDER AT
    MxA: A biomarker for predicting multiple sclerosis disease activity.
    Neurology. 2010;75:1222-3.
    PubMed     Text format     Related articles   



  175. VAN DER VOORT LF , Vennegoor A, Visser A, Knol DL, et al
    Spontaneous MxA mRNA level predicts relapses in patients with recently diagnosed MS.
    Neurology. 2010;75:1228-33.
    PubMed     Text format     Related articles    Abstract available



    September 2010
  176. VAN RENSBURG SJ , van Toorn R
    The controversy of CCSVI and iron in multiple sclerosis: Is ferritin the key?
    Neurology. 2010.
    PubMed     Text format     Related articles   



  177. TAVEE J , Stone L
    Healing the mind: Meditation and multiple sclerosis.
    Neurology. 2010;75:1130-1.
    PubMed     Text format     Related articles   



  178. GROSSMAN P , Kappos L, Gensicke H, D'Souza M, et al
    MS quality of life, depression, and fatigue improve after mindfulness training: A randomized trial.
    Neurology. 2010;75:1141-9.
    PubMed     Text format     Related articles    Abstract available



  179. AMATO MP , Goretti B, Ghezzi A, Lori S, et al
    Cognitive and psychosocial features in childhood and juvenile MS: two-year follow-up.
    Neurology. 2010;75:1134-40.
    PubMed     Text format     Related articles    Abstract available



  180. KRUPP LB , Benedict RH
    Down a slippery slope: cognitive changes in pediatric MS.
    Neurology. 2010;75:1128-9.
    PubMed     Text format     Related articles   



  181. RUTS L , Drenthen J, Jongen JL, Hop WC, et al
    Pain in Guillain-Barre syndrome. A long-term follow-up study.
    Neurology. 2010.
    PubMed     Text format     Related articles    Abstract available



  182. GORSON KC
    This disorder has some nerve. Chronic pain in Guillain-Barre syndrome.
    Neurology. 2010.
    PubMed     Text format     Related articles   



  183. ZHANG HL , Wu J, Ni FM, Kaji R, et al
    Undiminished regulatory T cells in the thymus of patients with myasthenia gravis.
    Neurology. 2010;75:1121.
    PubMed     Text format     Related articles   



  184. NOLANO M , Provitera V, Caporaso G, Stancanelli A, et al
    Quantification of pilomotor nerves: a new tool to evaluate autonomic involvement in diabetes.
    Neurology. 2010;75:1089-97.
    PubMed     Text format     Related articles    Abstract available



  185. COLLONGUES N , Marignier R, Zephir H, Papeix C, et al
    Long-term follow-up of neuromyelitis optica with a pediatric onset.
    Neurology. 2010;75:1084-8.
    PubMed     Text format     Related articles    Abstract available



  186. SELIM MM , Wendelschafer-Crabb G, Redmon JB, Khoruts A, et al
    Gastric mucosal nerve density: a biomarker for diabetic autonomic neuropathy?
    Neurology. 2010;75:973-81.
    PubMed     Text format     Related articles    Abstract available



  187. GHEZZI A , Pozzilli C, Grimaldi LM, Brescia Morra V, et al
    Safety and efficacy of natalizumab in children with multiple sclerosis.
    Neurology. 2010;75:912-7.
    PubMed     Text format     Related articles    Abstract available



    August 2010
  188. INGRAM G , Hirst CL, Robertson NP, Rolak LA, et al
    What is the risk of permanent disability from a multiple sclerosis relapse?
    Neurology. 2010;75:837-8.
    PubMed     Text format     Related articles   



  189. CROSS AH , Parks BJ
    The four seasons of multiple sclerosis.
    Neurology. 2010;75:762-3.
    PubMed     Text format     Related articles   



  190. LENHARD T , Biller A, Mueller W, Metz I, et al
    Immune reconstitution inflammatory syndrome after withdrawal of natalizumab?
    Neurology. 2010;75:831-3.
    PubMed     Text format     Related articles   



  191. MEIER DS , Balashov KE, Healy B, Weiner HL, et al
    Seasonal prevalence of MS disease activity.
    Neurology. 2010;75:799-806.
    PubMed     Text format     Related articles    Abstract available



  192. CALABRESE M , Battaglini M, Giorgio A, Atzori M, et al
    Imaging distribution and frequency of cortical lesions in patients with multiple sclerosis.
    Neurology. 2010.
    PubMed     Text format     Related articles    Abstract available



  193. GEURTS JJ , Vrenken H
    Toward understanding cortical lesions in multiple sclerosis.
    Neurology. 2010.
    PubMed     Text format     Related articles   



  194. EXLEY C
    Combined effects of smoking, anti-ebna antibodies, and hla-drb1*1501 on multiple sclerosis risk.
    Neurology. 2010;75:752.
    PubMed     Text format     Related articles   



  195. STAFF NP , Figueroa JJ, Parisi JE, Klein CJ, et al
    Hypertrophic nerves producing myelopathy in fulminant CIDP.
    Neurology. 2010;75:750.
    PubMed     Text format     Related articles   



  196. HEALY BC , Liguori M, Tran D, Chitnis T, et al
    HLA B*44: Protective effects in MS susceptibility and MRI outcome measures.
    Neurology. 2010;75:634-40.
    PubMed     Text format     Related articles    Abstract available



  197. AIRAS L , Jalkanen A, Alanen A, Pirttila T, et al
    Breast-feeding, postpartum and prepregnancy disease activity in multiple sclerosis.
    Neurology. 2010;75:474-6.
    PubMed     Text format     Related articles   



  198. O'BRIEN M , Lonergan R, Costelloe L, O'Rourke K, et al
    OAS1: A multiple sclerosis susceptibility gene that influences disease severity.
    Neurology. 2010;75:411-418.
    PubMed     Text format     Related articles    Abstract available



  199. KIESEIER BC , Wiendl H
    Postpartum disease activity and breastfeeding in multiple sclerosis revisited.
    Neurology. 2010;75:392-3.
    PubMed     Text format     Related articles   



  200. COHEN AB , Rizzo JF 3rd
    Teaching NeuroImages: Central retinal artery occlusion with cilioretinal artery sparing in giant cell arteritis.
    Neurology. 2010;75:e21-2.
    PubMed     Text format     Related articles   



  201. SLAVIN AJ , Zamvil SS
    FTY720 and central memory: out of sight, out of mind.
    Neurology. 2010;75:388-9.
    PubMed     Text format     Related articles   



    July 2010
  202. MATIELLO M , Kim HJ, Kim W, Brum DG, et al
    Familial neuromyelitis optica.
    Neurology. 2010;75:310-5.
    PubMed     Text format     Related articles    Abstract available



  203. RUDICK RA , Kappos L
    Measuring disability in relapsing-remitting MS.
    Neurology. 2010;75:296-7.
    PubMed     Text format     Related articles   



  204. KISTER I , Chamot E, Bacon JH, Niewczyk PM, et al
    Rapid disease course in African Americans with multiple sclerosis.
    Neurology. 2010;75:217-23.
    PubMed     Text format     Related articles    Abstract available



  205. TAKANO R , Misu T, Takahashi T, Sato S, et al
    Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study.
    Neurology. 2010;75:208-16.
    PubMed     Text format     Related articles    Abstract available



  206. GIOVANNONI G
    CSF GFAP: Volcanic ash from anti-aquaporin-4 antibody-mediated destruction of astrocytes.
    Neurology. 2010;75:200-1.
    PubMed     Text format     Related articles   



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: